Axonics Modulation Technologies (NASDAQ: AXNX) reported Q1 EPS of ($0.57), $0.16 worse than the analyst estimate of ($0.41). Revenue for the quarter came in at $34.4 million versus the consensus estimate of $27.88 million.

GUIDANCE:

Axonics Modulation Technologies sees FY2021 revenue of $176-180 million.

For earnings history and earnings-related data on Axonics Modulation Technologies (AXNX) click here.